CSK6-derived peptide inhibitor for breast cancer therapy

Women are central to the social and economic development of every nation, driving progress in education, healthcare, and the workforce. However, breast cancer, the most commonly diagnosed and leading cause of cancer-related deaths among women worldwide (Bray et al., 2024), poses a major threat to this foundation. Beyond its personal toll, breast cancer disrupts families, reduces workforce participation, and weakens community resilience.